IP Cases — 2026
1,011 decisions across all jurisdictions
Page 30 of 34 · 1,011 total
EOFlow Co., Ltd. v.Insulet Corporation
This appeal concerns a confidentiality request filed by EOFlow in proceedings related to a preliminary injunction finding that its insulin pump products infringe Insulet's European patent EP 4 201 327. The Court of Appeal held that there is no implicit limitation on the use of information received as a result of compliance with a court order to communicate information under Art. 67 UPCA and R. 191 RoP, and that EOFlow should have filed a R. 262A RoP application rather than relying on R. 262.2 RoP. The Court granted Insulet access to the documents labelled 'confidential,' denied EOFlow's request to restrict Insulet's use of the communicated information, and declined to decide on the remaining requests at that stage.
Google LLC v.Clear Imaging Research LLC
Google petitions the PTAB to invalidate Clear Imaging’s 32‑claim video‑stabilization patent, alleging obviousness over four prior‑art references and arguing claim‑term constructions. The petition seeks cancellation of all claims.
M/S Coral Drugs Private Limited v.The Assistant Controller Of Patents And Designs and Anr
The appeal challenged the Assistant Controller's refusal of a patent application (No. 201717022856) due to lack of inventive step. The appellant sought permission to amend its claims, which were subsequently accepted by the High Court provided they did not broaden the scope of the original claims.
Corning Incorporated v.The Controller Of Patents
Corning Incorporated filed an appeal challenging the rejection of its patent application (No. 202018041017) by The Controller of Patents. The court first condoned a delay of 14 days in filing the appeal and subsequently granted time to both parties for written submissions before listing the matter again.
Agathon AG v.Intercom s.r.l.,KNARR Vertriebs GmbH
This order was issued by the judge-rapporteur of the Milan Local Division following an online interim conference held on 27 January 2026 in consolidated proceedings UPC CFI no. 727/2024 and no. 493/2025. The order addresses procedural matters including the exploration of settlement, clarification of the Claimant's conditional auxiliary requests filed under R. 30.1 RoP, the admissibility of late-filed technical drawings (Annexes 27/28–33/34), and the parties' agreement on the use of a specific equivalence criterion from a prior UPC decision. The Court deemed the late-filed annexes admissible while reserving judgment on their relevance, and confirmed that the auxiliary requests would only be assessed if the counterclaim for revocation is upheld.
Labrador Diagnostics LLC v.bioMérieux SA. a. o.
Labrador Diagnostics LLC brought an infringement action against bioMérieux SA and five of its European subsidiaries concerning European patent EP 3 756 767 B1, which relates to instruments and methods for detecting biological analytes. The Düsseldorf Local Division bifurcated the case, referring the counterclaim for revocation to the Milan Central Division, which amended the patent to maintain only two claims. The court dismissed the infringement action, finding no direct or indirect infringement of the amended claims by the challenged VIDAS 3 instrument and related reagent strips and Solid Phase Receptacles, and ordered the Claimant to bear the costs.
Neway Industries Pvt. Ltd. v.Mold-Tek Packaging Limited
Mold-Tek Packaging Ltd filed a suit for infringement against Neway Industries Pvt. Ltd regarding two patents related to pail closure systems and tamper-proof lids. The dispute reached the Delhi High Court, where appeals were heard concerning the validity of the patents and the status of interim injunctions.
Canva Pty Ltd & Ors. v.Rxprism Health Systems Private Limited & Anr.
Canva appealed a single judge's decision that had granted an interim injunction against its 'Present and Record' feature, alleging infringement of Rxprism Health Systems Private Limited's Indian Patent No. 360726. The appeal challenged the finding of infringement and the direction to deposit Rs. 50 lakhs as security.
Rexcin Pharmaceuticals P Ltd v.Rekin Pharma P Ltd & Anr.
Rexcin Pharmaceuticals filed a suit seeking permanent injunction against Rekin Pharma regarding trademark infringement, passing off, and domain name misuse. The core dispute revolved around the similarity between 'REXCIN' (Petitioner) and 'REKIN-SP' (Respondent), particularly concerning pharmaceutical goods in Class 5. The court dismissed the interim injunction application, finding that the Petitioner failed to establish continuous use of REXCIN as a source identifier for Class 5 products.
ALD France S.A.S v.Nanoval GmbH & Co. KG
This case concerns a nullity action filed by ALD France S.A.S against Nanoval GmbH & Co. KG regarding European Patent EP 3 083 107 B1. Nanoval had previously filed an infringement action against ALD France's parent company (ALD Vacuum Technologies GmbH) at the Munich Local Division, where the parent had already filed a nullity counterclaim. Nanoval objected under Rule 19 of the Rules of Procedure, arguing that ALD France lacked a separate interest in filing its own nullity action. The court held that a subsidiary's own business activity establishes an independent interest in filing a nullity action, and that related companies are not automatically the 'same party' under Article 33(4) sentence 2 of the EPG Agreement merely because one is the parent of the other.
Amazon.com, Inc. Amazon Europe Core S.a.r.l, Amazon EU S.a.r.l., Amazon Media EU S.à.r.l., Amazon Technologies, Inc. Amazon.com Services LLC v.InterDigital Madison Patent Holdings, SAS
1 ORDER of the President of the Court of First Instance in the proceedings before the Local Division MANNHEIM Pursuant to R. 323 RoP (language of the proceedings) Issued on 26 January 2026 KEYWORDS - Change of the language of the proceedings – Art. 49 (5) UPCA and R. 323 RoP
Merz Pharmaceuticals LLC, Merz Therapeutics GmbH, Merz Pharma France v.Viatris Santé
This order from the Court of Appeal addresses a request under Rule 262.2 of the Rules of Procedure concerning the confidentiality of information in written pleadings or evidence. The Court clarified that only Rule 262A RoP permits restricting the opposing party's use of confidential information, and that a Rule 262.2 request does not automatically grant provisional protection against disclosure. The Court further explained the proper procedure for confidentiality orders, including the requirement to file a simultaneous Rule 262A application when lodging confidential documents, and noted that documents uploaded under HC code without a legal basis will routinely be reclassified to M code to ensure access by the other parties.
Sun Patent Trust v.Vivo Mobile Communication Co., Ltd., Vivo Tech GmbH, Vivo Mobile Communication Iberia SL and APPLE Inc. (intervener)
This order of the Court of Appeal concerns a confidentiality request under Rule 262A of the Rules of Procedure. The Court addressed the proportionality of measures protecting confidential information, balancing the right to an effective remedy and fair trial against the interests of parties and third parties. Key issues included whether employees of a party should be granted access to confidential information, the treatment of licence agreement information, and the liability framework for breaches of confidentiality obligations.
TELEFONAKTIEBOLAGET LM ERICSSON v.ASUSTEK Computer inc., Arvato Netherlands B.
This Final Order of the Court of Appeal concerns an application for the protection of confidential information under Rule 262A of the Rules of Procedure in proceedings between Telefonaktiebolaget LM Ericsson (as appellant/claimant) and ASUSTeK Computer Inc. and Arvato Netherlands B.V. (as respondents/defendants, jointly 'ASUS'). The Court addressed the proportionality of confidentiality measures, particularly regarding access to confidential information by employees of the parties and the application of an 'External Eyes Only' regime. The Court established that employees of a party should generally be granted access to confidential information, subject to appropriate judicial control, and that potential harm to third parties from licensing-related confidential information may be mitigated by barring the employee from involvement in licensing negotiations for a defined period.
Nordmeccanica S.p.A. v.Bobst Manchester Limited
This order concerns a procedural application by the Defendant, Nordmeccanica S.p.A., to change the language of proceedings from German to English in an infringement action brought by Bobst Manchester Limited based on European patent EP3067437. The Defendant argued that neither party has a business connection with Germany, that English is the prominent language in the relevant technical field, and that the change would promote procedural economy. The Claimant did not submit additional comments on the merits of the application.
Applicant *** v.Respondent
The President of the Court of Appeal reviewed a petition challenging the Registrar's refusal to enter the applicant on the list of representatives before the Unified Patent Court. The applicant had submitted his application on 29 August 2025, relying on a 'Kandidatenkurs Fischbachau' Certificate from 1989 under Rule 12.1(a) of the EPLC Rules, but the Registrar rejected it as filed outside the one-year transition period from the entry into force of the UPCA on 1 June 2023. The President held that the one-year time limit in Rule 12.1 of the EPLC Rules is not discriminatory and dismissed the petition.
SAMSUNG ELECTRONICS CO., LTD. et al. v.AQ Corporation
Samsung Electronics has filed an IPR petition challenging AQ Corporation’s U.S. Patent 11,728,564 covering a smartphone antenna module. The petition asserts that all 22 claims are obvious over multiple prior‑art references and seeks cancellation of the claims.
SAMSUNG ELECTRONICS CO., LTD. et al. v.AQ Corporation
Samsung has filed an IPR petition challenging AQ Corp's ’564 smartphone antenna patent, asserting that all 22 claims are obvious over multiple prior‑art references covering dual‑side coil layouts, NFC, MST and wireless charging. The petition seeks cancellation of claims 1‑20 under 35 U.S.C. §311.
M/s Anondita Healthcare v.Faiz Mohammad S/O Abdul Rahim
The dispute arose from an injunction decree passed against Faiz Mohammad and others, concerning the unauthorized use of proprietary design/technology for manufacturing surgical gloves. The Decree-holders challenged the Executing Court's order maintaining the attachment of one machine during execution proceedings. The High Court held that the executing court cannot undertake a fresh inquiry into IP rights or infringement, setting aside the attachment order.
M/s Anondita Healthcare v.Sware Health Care Pvt. Ltd.
The dispute arose from an injunction decree concerning the unauthorized use and fabrication of machines designed for manufacturing surgical gloves. The Decree-holders (Anondita Healthcare) sought to maintain attachment of a second machine during execution proceedings, alleging violation of their design rights. The High Court ruled that the executing court cannot undertake fresh substantive inquiry into IP infringement, setting aside the order maintaining the attachment.
Guardant Health, Inc. v.Sophia Genetics SA, Sophia Genetics SAS, Sophia Genetics SRL, Sophia Genetics GmbH
Guardant Health, Inc. sought provisional measures against the Sophia Genetics group before the Paris Local Division, alleging infringement of four European patents (EP 3470533, EP 3591073, EP 3443066, EP 3766986) relating to liquid biopsy technology for cancer diagnosis. The Court addressed three key issues: whether the Applicant had delayed unreasonably in filing the application, whether the divisional patent contained added matter, and whether the Applicant had demonstrated infringement with sufficient certainty. The Court found that a three-month delay was reasonable given the complexity of the case, that the divisional patent contained added matter because the claimed invention could not be directly and unambiguously derived from the original PCT application, and that the Applicant failed to meet its burden of proof for infringement by relying solely on a press release.
Van Loon Beheer Nederland B.V. v.Inverquark Deutschland GmbH a. o.
This case concerns European Patent EP 3 653 275 B8 and involves a dispute between Van Loon Beheer Nederland B.V. (applicant) and Inverquark Deutschland GmbH and Inverquark GmbH (respondents). The applicant had previously obtained an ex parte inspection and evidence preservation order executed at the respondents' trade fair stand at 'Aquanale Köln' on October 30, 2025. After initially indicating they would seek review of that order, the respondents withdrew that intention and instead requested the appointment of a supplementary expert opinion and the release of the detailed description prepared by the court-appointed expert.
Google LLC et al. v.HEADWATER RESEARCH LLC
The PTAB held that claims 1‑17, 19, 21‑27, 29 and 30 of Headwater Research’s ’733 patent are unpatentable. Google and Samsung successfully proved obviousness over the MMS 3GPP spec and the Ogawa encryption device.
Strategy Inc v.Web3AI Technologies, LLC
Strategy Inc (formerly MicroStrategy) has filed an IPR petition challenging all 25 claims of Web3AI's U.S. Patent 9,218,574 covering a user interface for machine‑learning results. The challenger alleges obviousness over a combination of four prior‑art references (Johnson, Lin, Purcell, Mihaylov) under § 103. No institution decision has been made yet.
Tesla, Inc. v.Bulletproof Property Management, LLC
Tesla has filed an IPR petition challenging all ten claims of its vehicle gear‑selection patent, asserting obviousness over multiple prior‑art references. The petition seeks institution of the review and a finding that the claims are unpatentable.
P V Anand Kishore v.M/S Bhatt Electronics (P) Ltd.
This appeal before the Karnataka High Court challenged an order that held M/S Bhatt Electronics liable to pay Rs. 3,00,000 in damages for infringing registered designs and trademarks related to emergency lights. The original suit was filed under the Trade and Merchandise Marks Act and Designs Act. While the appellant argued that the plaintiff failed to provide direct evidence of manufacturing or sales linking them to the infringement, the High Court upheld the trial court's finding. The court concluded that since there was no denial by the defendant regarding the sale of the product, the liability for damages could be inferred from the facts and circumstances.
Fresenius Kabi Oncology Ltd v.The Asst Controller Of Patents And Designs
Fresenius Kabi Oncology Ltd appealed the Assistant Controller's decision refusing its divisional patent application for 'PHARMACEUTICAL COMPOSITIONS OF PEMETREXED'. The refusal was based on the prior refusal of the mother application. However, since the mother application was subsequently granted, the High Court found the reason for refusal no longer tenable.
Merck Sharp & Dohme Corp. v.Ranvir Kumar Bindeshwari Singh
Merck Sharp & Dohme Corp. filed a suit seeking permanent injunction and damages against Ranvir Kumar Bindeshwari Singh for infringing Patent No. 209816, which covers SITAGLIPTIN. The court ultimately decreed the suit in favor of the plaintiffs, awarding substantial compensatory, exemplary, and costs damages.
Incyte Holdings Corporation v.Intas Pharmaceuticals Ltd
The suit was filed alleging infringement of Patent No. 269841 (IN'841) by Intas Pharmaceuticals Ltd regarding the compound Ruxolitinib. After discussions, the Defendant provided an undertaking that they would not commercialize the patented compound during the patent's validity. The court accepted this undertaking and disposed of the suit on consent terms.
Jesal Vimal Jetha v.Controller General Of Patents, Designs and Trade Marks
The appeal challenged the Controller's refusal of a patent application for a customizable comforter system, citing failure to meet objections under Section 2(1)(ja). The appellant argued that the decision was mechanical and violated natural justice due to procedural irregularities in handling prior art documents. The High Court set aside the order and remanded the matter for fresh consideration.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.